RT Journal Article
SR Electronic
T1 A deep learning approach with event-related spectral EEG data in attentional deficit hyperactivity disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19005611
DO 10.1101/19005611
A1 Laura Dubreuil-Vall
A1 Giulio Ruffini
A1 Joan A. Camprodon
YR 2019
UL http://medrxiv.org/content/early/2019/09/11/19005611.abstract
AB Attention deficit hyperactivity disorder (ADHD) is a heterogeneous neurodevelopmental disorder that affects 5% of the pediatric and adult population worldwide. The diagnosis remains essentially clinical, based on history and exam, with no available biomarkers. In this paper, we describe a deep convolutional neural network (DCNN) for ADHD classification derived from the time-frequency decomposition of electroencephalography data (EEG), particularly of event-related potentials (ERP) during the Flanker Task collected from 20 ADHD adult patients and 20 healthy controls (HC). The model reaches a classification accuracy of 88%, superior to resting state EEG spectrograms and with the key advantage, compared with other machine learning approaches, of avoiding the need for manual selection of EEG spectral or channel features. Finally, through the use of feature visualization techniques, we show that the main features exciting the DCNN nodes are a decreased power in the alpha band and an increased power in the delta-theta band around 100ms for ADHD patients compared to HC, suggestive of attentional and inhibition deficits, which have been previously suggested as pathophyisiological signatures of ADHD. While confirmation with larger clinical samples is necessary, these results highlight the potential of this methodology to develop CNS biomarkers of practical clinical utility.Competing Interest StatementLDV is an employee at Neuroelectrics and a PhD student in the Camprodon Lab. GR is a co-founder of Neuroelectrics, a company that manufactures the EEG device used in this study. JAC is a member of the scientific advisory board for Apex Neuroscience Inc.Funding StatementThis research was partly supported by NIH grants (RO1 MH112737, R21 DA042271, R21 AG056958 and R21 MH113018) and the Louis V. Gerstner III Research Scholar Award to JAC.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableThe datasets generated and analyzed during the current study are available from the senior author (JAC) on reasonable request.